
Joel Goldstein, PhD
Advertisement
Joel Goldstein, PhD is associate director, transfectoma development, at Medarex Inc.
Articles by Joel Goldstein, PhD

Advertisement
Latest Updated Articles
The Impact of Cell Culture Medium on Cell Line and Process Development Timelines and StrategiesPublished: June 2nd 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Ultragenyx Phase III Data Reveal Limits of Bone Density Endpoints in Rare Bone Disease
2
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
3
Accelerate Your Biologic with HEK Cell Lines
4
